Cardiac Inflammation Research Group
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The prognostic value of global longitudinal strain in patients with myocardial infarction and preserved ejection fraction : a prespecified substudy of the REDUCE-AMI trial
- Contribution to journal › Article
-
Mark
Marine-derived nutritional and bioactive compounds : Proteins and amino acids
(2025) p.263-298
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
- Contribution to journal › Article
-
Mark
Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction
- Contribution to journal › Article
- 2024
-
Mark
A study of size-selective renal elimination using a novel human model
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- Contribution to journal › Article
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients
- Contribution to journal › Article
